SCHEMBL29355115

SCHEMBL29355115

Nc1nc2c(ncn2[C@@H]2O[C@H](COP(=O)(O)O)[C@@H](OP(=O)(O)OP(=O)(O)O)[C@H]2O)c(=O)[nH]1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGM2 P21980 1/20 0.65
NT5E P21589 1/20 0.65
FUT5 Q11128 1/20 0.63
IMPDH2 P12268 6/20 0.60
IMPDH1 P20839 2/20 0.60
KRAS P01116 2/20 0.59
TAS1R3 Q7RTX0 2/20 0.59
TAS1R1 Q7RTX1 2/20 0.59
RNASEL Q05823 2/20 0.57
POLB P06746 1/20 0.57
ENPP1 P22413 2/20 0.57
P2RY1 P47900 2/20 0.57
P2RY12 Q9H244 1/20 0.57
P2RY6 Q15077 2/20 0.56
P2RX1 P51575 1/20 0.56
P2RX3 P56373 1/20 0.56
P2RY11 Q96G91 1/20 0.56
P2RX4 Q99571 1/20 0.56
P2RY2 P41231 1/20 0.56
P2RY4 P51582 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23176397 0.97 TGM2 (0.70) TGM2NT5EFUT5IMPDH2IMPDH1
SCHEMBL877839 0.97 TGM2 (0.70) TGM2NT5EFUT5IMPDH2IMPDH1
SCHEMBL234673 0.97 TGM2 (0.70) TGM2NT5EFUT5IMPDH2IMPDH1
SCHEMBL21067995 0.97 TGM2 (0.70) TGM2NT5EFUT5IMPDH2IMPDH1
SCHEMBL21256201 0.97 TGM2 (0.70) TGM2NT5EFUT5IMPDH2IMPDH1
SCHEMBL25567646 0.96 TGM2 (0.69) TGM2NT5EFUT5KRASRNASEL
SCHEMBL4011876 0.96 TGM2 (0.69) TGM2NT5EFUT5KRASRNASEL
SCHEMBL6512071 0.96 TGM2 (0.69) TGM2NT5EFUT5KRASRNASEL
SCHEMBL1533928 0.96 TGM2 (0.69) TGM2NT5EFUT5KRASRNASEL
SCHEMBL1533923 0.96 TGM2 (0.69) TGM2NT5EFUT5KRASRNASEL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119228928-A Sparse spiral CT image reconstruction method based on micro-spiral reconstruction operator 南方医科大学 2024-12-31 CN claimed
US-20260009054-A1 METHOD TO PRODUCE THE ANTI-MICROBIAL DITERPENOID LEUBETHANOL AND RELATED SERRULATANE-TYPE DITERPENES UNIV MICHIGAN STATE (US) 2026-01-08 US disclosed
EP-4303279-B1 AQUEOUS PIGMENT DISPERSION LIQUID, AQUEOUS INK-JET INK, AND DRY COATING DAINICHISEIKA COLOR CHEM (JP) 2025-12-10 EP disclosed
US-20250361532-A1 BIDIRECTIONAL MULTI-ENZYMATIC SCAFFOLDS FOR BIOSYNTHESIZING CANNABINOIDS KHONA SCIENT HOLDINGS INC (US) 2025-11-27 US disclosed
CN-120859946-A Preparation and application of poly-gossypol supermolecule prodrug nano micelle 宜宾西南大学研究院 2025-10-31 CN disclosed
US-12385072-B2 Bidirectional multi-enzymatic scaffolds for biosynthesizing cannabinoids KHONA SCIENTIFIC HOLDINGS, INC. (US) 2025-08-12 US disclosed
US-12378579-B2 Method to produce the anti-microbial diterpenoid leubethanol and related serrulatane-type diterpenes BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2025-08-05 US disclosed
US-12319825-B2 Ink jet ink composition and ink set SEIKO EPSON CORPORATION (JP) 2025-06-03 US disclosed
US-20250107541-A1 IMPROVED BIOLOGICALLY DERIVED FOOD PRESERVATIVE IMPACT BIOLIFE SCIENCE, INC. 2025-04-03 US disclosed
CN-119228928-A Sparse spiral CT image reconstruction method based on micro-spiral reconstruction operator 南方医科大学 2024-12-31 CN disclosed
US-20230151376-A1 ORGANELLE TRANSFORMANT SCREENING METHOD NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY (JP) 2023-05-18 US disclosed
EP-4137566-A1 ORGANELLE TRANSFORMANT SCREENING METHOD National University Corporation Kobe University (JP) 2023-02-22 EP disclosed
US-11525148-B2 Bidirectional multi-enzymatic scaffolds for biosynthesizing cannabinoids KHONA SCIENTIFIC HOLDINGS, INC. (US) 2022-12-13 US disclosed
US-20220380616-A1 Ink Jet Ink Composition And Ink Set SEIKO EPSON CORPORATION (JP) 2022-12-01 US disclosed
US-20220372526-A1 METHOD FOR PRODUCTION OF NOVEL DITERPENE SCAFFOLDS UNITED STATES DEPARTMENT OF ENERGY 2022-11-24 US disclosed
EP-4054542-A1 BIOSYNTHESIS OF CHEMICALLY DIVERSIFIED NON-NATURAL TERPENE PRODUCTS Board Of Trustees Of Michigan State University (US) 2022-09-14 EP disclosed
WO-2022185578-A1 AQUEOUS PIGMENT DISPERSION LIQUID, AQUEOUS INK-JET INK, AND DRY COATING 大日精化工業株式会社 2022-09-09 WO disclosed
CN-114410634-B Promoter derived from fusarium venenatum and visual gene knockout screening method 中国科学院天津工业生物技术研究所 2022-06-24 CN disclosed
US-11331305-B2 Peptides for skin rejuvenation and methods of using the same ANTEIS SA (CH) 2022-05-17 US disclosed
CN-215646952-U Movable high-scanning printing integrated machine 河北晨达电子科技有限公司 2022-01-25 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11331305-B2 Peptides for skin rejuvenation and methods of using the same CUTA, PLOD3, MMP13 TGM2 2189/4885NT5E 246/4885FUT5 890/4885
US-20260009054-A1 METHOD TO PRODUCE THE ANTI-MICROBIAL DITERPENOID LEUBETHANOL AND RELATED SERRULATANE-TYPE DITERPENES CYP51A1, LSS, FNTB TGM2 1340/4885NT5E 1417/4885FUT5 1667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.